Short Wave
What A New Antiviral Drug Could Mean For The Future Of COVID
Tue, 07 Dec 2021 05:10:59 +0000
From Default Workspace • No contributors
An advisory panel to the U.S. Food and Drug Administration advisory panel has voted to recommend that the FDA approve a new antiviral drug to treat COVID-19. The FDA decision is expected soon. Host Emily Kwong chats with health reporter Pien Huang on the state of treatments and how this drug and other treatment options may change the pandemic. For more of Pien's reporting, check out "New antiviral drugs are coming for COVID. Here's what you need to know." You can follow Emily on Twitter @EmilyKwong1234 and Pien @Pien_Huang. Email Short Wave at [email protected] more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy
No persons identified in this episode.
No transcription available yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster